唐兴物流有限公司
20人以下
公司优势
20,861+ 岗位更新等你来订阅
一键订阅最新的岗位，每周送达
🎉恭喜你，订阅成功
继续订阅您可以在邮箱中随时取消订阅
Vazyme - Innovation in Enzyme Technology
Founded in 2012 and located in the Nanjing High-tech Zone (stock code: 688105), Nanjing Vazyme Biotech Co., Ltd. is a biotechnology company focusing on the development of technological innovations and products related to enzymes, antigens, antibodies, and other functional proteins and high molecular organic materials. Leveraging its independently established key technology platform, the company has ventured into fields such as life sciences, in vitro diagnostics, and bio-pharmaceuticals. As one of the few companies in China with both upstream technology development capabilities and downstream product manufacturing capabilities, Vazyme aims to create "biochips" and continuously inject new vitality into the biotechnology industry.
Innovation and Talent Pool
Vazyme has always adhered to innovation and breakthroughs, insisting on developing from the source of technology. With its proprietary core technologies, it has built an independently controllable key technology platform that enables rapid, efficient, and large-scale product development. The company currently offers over 600 types of genetically engineered recombinant enzymes and more than 2,500 high-performance antigens and monoclonal antibodies, along with over 2,000 terminal products applicable to scientific research, high-throughput sequencing, in vitro diagnostics, pharmaceutical and vaccine development, and animal quarantine.
A strong R&D capability is supported by a robust talent pool. Vazyme boasts a team of nearly 700 R&D personnel, including experts in molecular biology, enzymology, immunology, bioinformatics, organic chemistry, and materials science. Over 67% of these R&D staff hold master’s degrees or higher.
Mastery of Core Raw Material Technologies and Downstream Industrial Advantages
Since its establishment, Vazyme has always adhered to a business philosophy centered around R&D, continuously upgrading its core technologies and expanding into new business areas. Through years of relentless efforts, Vazyme has achieved significant technical accomplishments in the fields of biology, healthcare, and pharmaceuticals. It has successfully launched various series of biological reagents, including high-throughput sequencing library construction, PCR, qPCR, molecular cloning, reverse transcription, and Bio-assay, as well as POCT diagnostic reagents covering nine categories such as cardiovascular diseases, inflammation, infections, reproductive health, gastric function, respiratory system, and nervous system. Its customer base includes research institutions, high-throughput sequencing service enterprises, molecular diagnostic reagent manufacturers, pharmaceutical companies, CROs, and hospitals.
Staying True to Our Mission and Fulfilling Responsibilities
While expanding its product and technology chains, Vazyme remains committed to its mission of "Technology for Healthier Lives," constantly developing new technologies, providing high-quality products, and professional services to contribute value to customers. Rooted in the principle of putting hardworking individuals first, Vazyme provides a broad development platform to attract outstanding talents from across the country and even the world, driving the overall development and enhancement of China's biotechnology and medical industries. Actively engaging in public health initiatives, Vazyme uses technology to support national biosafety efforts, helping humanity combat major infectious diseases, tumors, and autoimmune disorders!
主要从事互联网行业及相关业务
伊顿名师教育汇聚了一支由杰出教育专家组成的团队，他们深谙伊顿公学的教育哲学，坚持在教学实践中融入其独特的快乐精英教育模式，并巧妙地结合了古代智者孔子的"因材施教"原则，旨在培养学生的责任感、个性与使命感。我们的目标是激发每一位学员热爱学习、掌握高效学习方法并追求卓越，从而使其成为实现中华民族伟大复兴这一崇高使命的中流砥柱。
伊顿教育的核心理念是"精心惟伊，顿思引学"。我们以一颗细腻的心对待每一位学生，激发他们主动思考与探索的热情，唤醒他们内心深处的潜力，帮助他们成长为更优秀的个体。
通过伊顿名师教育，我们不仅传授知识，更重要的是培养学生的内在驱动力，使他们在成长的道路上不断超越自我，为社会的发展贡献自己的力量。
阜阳三九生物技术有限公司，以“只做中国含量最高的保健食品”为企业的定位；凭借“高含量的保健食品”在行业中享有盛誉；同时为客户创造价值，帮助员工实现梦想，是企业核心理念。90天内助力客户达成：产品畅销、顾客信赖、员工自信、名利双收！
主要经营电子商务，依托淘宝、拍拍等平台开展网络销售。公司尚处于起步阶段，仍有许多不足之处，我们将不断改进，恳请大家多提宝贵意见。